[1]杨泓娟,龚恬,项守奎.皮肤与骨质疏松症[J].国际内分泌代谢杂志,2024,44(03):202-205.[doi:10.3760/cma.j.cn121383-20230830-08074]
　Yang Hongjuan,Gong Tian,Xiang Shoukui..Skin and Osteoporosis[J].International Journal of Endocrinology and Metabolism,2024,44(03):202-205.[doi:10.3760/cma.j.cn121383-20230830-08074]
点击复制

皮肤与骨质疏松症 ()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
44
期数:
2024年03期
页码:
202-205
栏目:
综述
出版日期:
2024-05-20

文章信息/Info

Title:
Skin and Osteoporosis
作者:
杨泓娟; 龚恬; 项守奎
苏州大学附属第三医院内分泌代谢科,常州 213003
Author(s):
Yang Hongjuan;  Gong Tian;  Xiang Shoukui.
Department of Endocrinology, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China
关键词:
骨质疏松症;  皮肤结构;  皮肤疾病;  炎性因子;  老化
Keywords:
Osteoporosis;  Skin Structure;  Skin Disease;  Inflammatory Factor;  Aging
DOI:
10.3760/cma.j.cn121383-20230830-08074
摘要:
骨质疏松症是一种以骨量低下,骨组织微结构损坏,导致骨脆性增加,易发生骨折为特征的全身性骨病。皮肤作为人体最大的器官,皮肤结构的相关参数可作为预测骨质疏松症的标志物,例如皮肤厚度、皮肤弹性、体表面积等。研究证明,与皮肤疾病相关的一些炎症因子以及治疗药物影响着骨重塑的平衡; 皮肤老化与骨量流失存在一定的相关性,雌激素、晚期糖基化终产物和胱抑素A可能在两者之间发挥着重要作用。本文旨在对皮肤与骨质疏松症的相关性进行综述,进而为骨质疏松症的诊治提供新思路。
Abstract:
Osteoporosis is a systemic bone disease characterized by low bone mass and deterioration of bone microstructure, leading to increased bone fragility and susceptibility to fracture. As the largest organ of the body, structurally relevant parameters of the skin can be used as markers to predict osteoporosis, such as skin thickness, skin elasticity, body surface area, etc. It has been demonstrated that some inflammatory factors and therapeutic drugs associated with skin diseases affect the balance of bone remodeling. There is a certain correlation between skin aging and bone mass loss, and estrogen, advanced glycosylation end products and cystatin A may play an important role in them. The aim of this paper is to review the correlation between skin and osteoporosis, and thus provide new ideas for the diagnosis and treatment of osteoporosis.

参考文献/References:

[1] Wang L,Yu W,Yin X,et al.Prevalence of osteoporosis and fracture in China:the China osteoporosis prevalence study[J].JAMA network open,2021,4(8):e2121106.DOI:10.1001/jamanetworkopen.2021.21106.
[2] Si L,Winzenberg TM,Jiang Q,et al.Projection of osteoporosis-related fractures and costs in China:2010-2050[J].Osteoporos Int,2015,26(7):1929-37.DOI:10.1007/s00198-015-3093-2.
[3] Sorushanova A,Delgado LM,Wu Z,et al.The collagen suprafamily:from biosynthesis to advanced biomaterial development[J].Adv Mater,2019,31(1):e1801651.DOI:10.1002/adma.201801651.
[4] Lehmann TP,Guderska U,Kaek K,et al.The regulation of collagen processing by miRNAs in disease and possible implications for bone turnover[J].Int J Mol Sci,2021,23(1)91.DOI:10.3390/ijms23010091.
[5] Shuster S.Osteoporosis,like skin ageing,is caused by collagen loss which is reversible[J].J R Soc Med,2020,113(4):158-160.DOI:10.1177/0141076820910315.
[6] Mcconkey B,Fraser GM,Bligh AS.Transparent skin and osteoporosis:a study in patients with rheumatoid disease[J].Ann Rheum Dis,1965,24(3):219-223.DOI:10.1136/ard.24.3.219.
[7] Chappard D,Alexandre C,Robert JM,et al.Relationships between bone and skin atrophies during aging[J].Acta Anat(Basel),1991,141(3):239-244.DOI:10.1159/000147128.
[8] Yoneda Pde P,Biancolin SE,Gomes MS,et al.Association between skin thickness and bone density in adult women[J].An Bras Dermatol,2011,86(5):878-884.DOI:10.1590/s0365-05962011000500003.
[9] Sumino H,Ichikawa S,Abe M,et al.Effects of aging and postmenopausal hypoestrogenism on skin elasticity and bone mineral density in Japanese women[J].Endocr J,2004,51(2):159-164.DOI:10.1507/endocrj.51.159.
[10] Piérard GE,Piérard-Franchimont C,Vanderplaetsen S,et al.Relationship between bone mass density and tensile strength of the skin in women[J]. Eur J Clin Invest,2001,31(8):731-735.DOI:10.1046/j.1365-2362.2001.00841.x.
[11] Wu XP,Liao EY,Liu SP,et al.Relationship of body surface area with bone density and its risk of osteoporosis at various skeletal regions in women of mainland China[J]. Osteoporos Int,2004,15(9):751-759.DOI:10.1007/s00198-004-1608-3.
[12] Wu XY,Li HL,Shen Y,et al.Effect of body surface area on severe osteoporotic fractures:a study of osteoporosis in Changsha China[J].Front Endocrinol(Lausanne),2022,13:927344.DOI:10.3389/fendo.2022.927344.
[13] Noel SE,Santos MP,Wright NC.Racial and ethnic disparities in bone health and outcomes in the United States[J].J Bone Miner Res,2021,36(10):1881-1905.DOI:10.1002/jbmr.4417.
[14] 中国营养学会健康管理分会.维生素D营养状况评价及改善专家共识[J].2023,17(4):245-252.DOI:10.3760/cma.j.cn115624-20230105-00009.
[15] Sirufo MM,De Pietro F,Bassino EM,et al.Osteoporosis in skin diseases[J]. Int J Mol Sci,2020,21(13):4749.DOI:10.3390/ijms21134749.
[16] Tang M,Lu L,Yu X.Interleukin-17A interweaves the skeletal and immune systems[J].Front Immunol,2021,11:625034.DOI:10.3389/fimmu.2020.625034.
[17] Amarasekara DS,Kim S,Rho J.Regulation of osteoblast differentiation by cytokine networks[J]. Int J Mol Sci,2021,22(6):2851.DOI:10.3390/ijms22062851.
[18] Zheng LW,Wang WC,Mao XZ,et al.TNF-α regulates the early development of avascular necrosis of the femoral head by mediating osteoblast autophagy and apoptosis via the p38 MAPK/NF-κB signaling pathway[J].Cell Biol Int,2020,44(9):1881-1889.DOI:10.1002/cbin.11394.
[19] Liang W,Chen Q,Cheng S,et al.Skin chronological aging drives age-related bone loss via secretion of cystatin-A[J].Nature aging,2022,2(10):906-922.DOI:10.1038/s43587-022-00285-x.
[20] Wu D,Cline-Smith A,Shashkova E,et al.T-Cell mediated inflammation in postmenopausal osteoporosis[J].Front Immunol,2021,12:687551.DOI:10.3389/fimmu.2021.687551.
[21] Chen CY,Zhang JQ,Li L,et al.Advanced glycation end products in the skin:molecular mechanisms,methods of measurement,and inhibitory pathways[J].Front Med(Lausanne),2022,9:837222.DOI:10.3389/fmed.2022.837222.
[22] Gautieri A,Passini FS,Silván U,et al.Advanced glycation end-products:mechanics of aged collagen from molecule to tissue[J].Matrix Biol,2017,59:95-108.DOI:10.1016/j.matbio.2016.09.001.
[23] Poundarik AA,Wu PC,Evis Z,et al.A direct role of collagen glycation in bone fracture[J].J Mech Behav Biomed Mater,2015,52:120-130.DOI:10.1016/j.jmbbm.2015.08.012.
[24] Waqas K,Chen J,Koromani F,et al.Skin autofluorescence,a noninvasive biomarker for advanced glycation end-products,is associated with prevalent vertebral and major osteoporotic fractures:the rotterdam study[J].J Bone Miner Res,2020,35(10):1904-1913.DOI:10.1002/jbmr.4096.
[25] Wei R,Zhang L,Hu W,et al.CSTA plays a role in osteoclast formation and bone resorption by mediating the DAP12/TREM2 pathway[J].Biochem Biophys Res Commun,2022,627:12-20.DOI:10.1016/j.bbrc.2022.08.033.
[26] Ma M,Chen X,Lu L,et al.Identification of crucial genes related to postmenopausal osteoporosis using gene expression profiling[J].Aging Clin Exp Res,2016,28(6):1067-1074.DOI:10.1007/s40520-015-0509-y.

相似文献/References:

[1]齐保玉,魏戌,朱立国,等.血管生成在骨代谢及骨质疏松症中的作用研究进展[J].国际内分泌代谢杂志,2021,41(02):128.[doi:10.3760/cma.j.cn121383-20200326-03066]
　Qi Baoyu,Wei Xu,Zhu Liguo,et al.Research progress on the role of angiogenesis in bone metabolism and osteoporosis[J].International Journal of Endocrinology and Metabolism,2021,41(03):128.[doi:10.3760/cma.j.cn121383-20200326-03066]
[2]杨婷,岳月仪,范雨佳,等.WISP1与骨质疏松症关系的研究进展[J].国际内分泌代谢杂志,2021,41(03):224.[doi:10.3760/cma.j.cn121383-20200417-04051]
　Yang Ting,Yue Yueyi,Fan Yujia,et al.Research progress on the relationship between WISP1 and osteoporosis[J].International Journal of Endocrinology and Metabolism,2021,41(03):224.[doi:10.3760/cma.j.cn121383-20200417-04051]
[3]晁爱军.地舒单抗和罗莫佐单抗治疗骨质疏松症的进展及展望[J].国际内分泌代谢杂志,2023,43(04):283.[doi:10.3760/cma.j.cn121383-20230708-07013]
　Chao Aijun.Progress and prospects of denosumab and romosozumab in osteoporosis treatment[J].International Journal of Endocrinology and Metabolism,2023,43(03):283.[doi:10.3760/cma.j.cn121383-20230708-07013]

备注/Memo

备注/Memo:
通信作者:项守奎,Email:xsk8012@163.com
基金项目:常州市医学拔尖人才项目(2022260)
更新日期/Last Update: 2024-05-30